medicinal cannabis
Chemist Warehouse joins cannabis company joint venture
Wellnex Life aims to launch five special access medicinal cannabis products by the end of June 2023 via CWH network Chemist Warehouse will receive a 10% interest in an existing …
One Nation Bill sets pathway for cannabis PBS listing
Legislation put before the Senate this week could pave the way for medicinal cannabis products to be listed on the Pharmaceutical Benefits Scheme (PBS) Under the proposed Improving Access to …
Research Roundup
Debbie Rigby takes a look at the latest in research news Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN) For patients with heart …
A need for training
While a majority of Australian pharmacists endorse the provision of low-dose cannabis-based medicines, most lack confidence in discussing them with patients and say they need more training A new Australian …
First OTC cannabis by early 2023?
Wellnex Life hoping for SAS OK by year’s end with S3 approval to follow in next quarter – and a market potentially worth “billions” ASX-listed health and wellness outfit Wellnex …
World news wrapup: 22 September 2022
US pharmacist keeps license after faking COVID jabs; Irish pharmacy shortage worsens; Nevada Pharmacy Board loses cannabis case East Wenatchee, Washington State: A pharmacist has agreed to pay a USD$1,000 …
Research Roundup
Debbie Rigby takes a look at the latest in research news Long-term and serious harms of medical cannabis and cannabinoids for chronic pain A systematic review and meta-analysis of 39 …
Legal cannabis use on the rise
The number of Australians accessing cannabis legally via prescriptions has soared, new research shows – though many still obtain it illicitly to self-medicate New research from the University of Sydney’s …
‘There’s a fair degree of trial and error at the moment.’
Chronic non-cancer pain is the leading indication for special access to medicinal cannabis products, despite doctors being urged not to prescribe for this indication Medicinal cannabis applications for chronic pain …
World News Wrapup: 30 June 2022
Walgreens takes Boots off the market; the pharmaceutical impact of the US Supreme Court overturning Roe v Wade: Pharmacy to boost cheaper cannabis sales US: Pharmacy giant Walgreens has dropped …
Research Roundup
Debbie Rigby takes a look at the latest in research news Cannabis-Based Products for Chronic Pain A systematic review of 18 RCTs and 7 cohort studies has concluded that oral …
‘Dramatic increase’ in cannabis approvals in past two years
Medicinal cannabis has been prescribed for over 140 conditions since the beginning of the program, with anxiety a leading indication, new study finds Since Australia’s medicinal cannabis program began in …